BRCA1/2 germline mutated populations have also shown exceptional sensitivity to PARP
inhibitors (PARPi)
Defining BRCAness Phenotype
Tan D JCO 2008; Fong FC JCO 2010; Audeh MW Lancet 2010; Ledermann J Lancet 2014; Fong FC NEJM 2009
Audeh Lancet 2010